Debaditya Bhattacharya

Debaditya Bhattacharya, Ph.D., is a seasoned expert in the fields of CMC strategy, product development, and analytical operations within the biotechnology sector. Currently serving as a Consultant at Myrtelle since April 2025, Debaditya previously held notable leadership roles including Vice President at ElevateBio, overseeing analytical CMC from December 2022 to March 2025, and Senior Director at CRISPR Therapeutics, where a team of 30 was built for the characterization of CAR-T drug products. With prior experience at bluebird bio and Aura Biosciences in analytical and product development, respectively, and a solid foundational education culminating in a Ph.D. from Tufts University, Debaditya possesses a comprehensive background in molecular biology, biotechnology, and strategic operational leadership in the development of innovative therapeutics.